News List

Novartis' asciminib bests Pfizer's Bosulif in phase 3 leukemia trial
2021-11-02

Novartis’ asciminib hasoutperformedPfizer’s Bosulif in a phase 3 chronic myeloid leukemia (CML) stud

Hengrui announces new drug SHR7280
2021-10-16

On October 11, 2021, Jiangsu Hengrui Pharmaceuticals Co., Ltd. announced that SHR0302, for the treat

Novartis secures new approval in China for Cosentyx® (secukinumab) in pediatric psoriasis
2021-08-23

August 17, 2021 – Novartis today announced that the China National Medical Products Administration (

Bayer’s new symptomatic chronic heart failure treatment Verquvo™ (vericiguat) approved in EU
2021-07-27

Berlin, Germany, July 21, 2021– The European Commission has granted marketing authorization in the E

USFDA approves KIT inhibitor Ayvakit (Avatinib)
2021-06-25

CStone's partner Blueprint Medicines recently announced that the U.S. Food and Drug Administrati

Xofluza was approved in China
2021-05-13

On April 29, 2021, Roche China announced that its innovative influenza drug Xofluza® (Mabaloxavir) h

Tagrisso approved in China in early lung cancer
2021-04-16

AstraZeneca'sTagrisso(osimertinib) has been approved in China for the adjuvant treatment of pati

Gilead’s Investigational Lenacapavir Demonstrates Sustained Long-Acting Efficacy Through Week 26 in Data Presented at CROI
2021-03-15

Gilead Sciences, Inc. (Nasdaq: GILD) today presented additional results from the Phase 2/3 CAPELLA t